Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01926587
Title Oral Rigosertib in Combination With Azacitidine
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Onconova Therapeutics, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
City of Hope Duarte California 91010 United States Details
Desert Hematology Oncology Medical Group, Inc. Rancho Mirage California 92270 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
Cancer Center of Kansas Wichita Kansas 67214 United States Details
Saint Louis University Saint Louis Missouri 63110 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Mount Sinai Medical Center New York New York 10029 United States Details
White Plains Hospital Center for Cancer Care White Plains New York 10601 United States Details
Carolina Blood and Cancer Care Associates Rock Hill South Carolina 29732 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
Hôpital St. Louis Paris 75475 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field